Free Trial

FONAR (FONR) Competitors

FONAR logo
$14.57 -0.37 (-2.48%)
Closing price 03/3/2025 04:00 PM Eastern
Extended Trading
$14.61 +0.04 (+0.27%)
As of 03/3/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FONR vs. ZIMV, NYXH, LUNG, TCMD, NNOX, CVRX, SMTI, AVR, RCEL, and ZYXI

Should you be buying FONAR stock or one of its competitors? The main competitors of FONAR include ZimVie (ZIMV), Nyxoah (NYXH), Pulmonx (LUNG), Tactile Systems Technology (TCMD), Nano-X Imaging (NNOX), CVRx (CVRX), Sanara MedTech (SMTI), Anteris Technologies Global (AVR), AVITA Medical (RCEL), and Zynex (ZYXI). These companies are all part of the "medical equipment" industry.

FONAR vs.

ZimVie (NASDAQ:ZIMV) and FONAR (NASDAQ:FONR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, risk, community ranking, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.

ZimVie has a beta of 2.1, indicating that its share price is 110% more volatile than the S&P 500. Comparatively, FONAR has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500.

FONAR received 176 more outperform votes than ZimVie when rated by MarketBeat users. Likewise, 74.69% of users gave FONAR an outperform vote while only 23.53% of users gave ZimVie an outperform vote.

CompanyUnderperformOutperform
ZimVieOutperform Votes
4
23.53%
Underperform Votes
13
76.47%
FONAROutperform Votes
180
74.69%
Underperform Votes
61
25.31%

FONAR has a net margin of 7.68% compared to ZimVie's net margin of -77.31%. FONAR's return on equity of 4.94% beat ZimVie's return on equity.

Company Net Margins Return on Equity Return on Assets
ZimVie-77.31% 2.90% 1.17%
FONAR 7.68%4.94%3.70%

FONAR has lower revenue, but higher earnings than ZimVie. ZimVie is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ZimVie$449.75M0.83-$393.28M-$0.95-14.19
FONAR$101.57M0.89$10.57M$1.1512.67

In the previous week, ZimVie had 13 more articles in the media than FONAR. MarketBeat recorded 14 mentions for ZimVie and 1 mentions for FONAR. FONAR's average media sentiment score of 1.87 beat ZimVie's score of 0.41 indicating that FONAR is being referred to more favorably in the news media.

Company Overall Sentiment
ZimVie Neutral
FONAR Very Positive

95.6% of ZimVie shares are held by institutional investors. Comparatively, 50.6% of FONAR shares are held by institutional investors. 3.0% of ZimVie shares are held by insiders. Comparatively, 2.2% of FONAR shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

ZimVie presently has a consensus target price of $19.50, indicating a potential upside of 44.66%. Given ZimVie's stronger consensus rating and higher probable upside, analysts clearly believe ZimVie is more favorable than FONAR.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ZimVie
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
FONAR
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

FONAR beats ZimVie on 10 of the 18 factors compared between the two stocks.

Get FONAR News Delivered to You Automatically

Sign up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FONR vs. The Competition

MetricFONARElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$90.38M$3.48B$5.81B$8.39B
Dividend YieldN/A1.62%4.75%3.98%
P/E Ratio12.6717.1024.9519.21
Price / Sales0.8958.22375.54110.22
Price / Cash4.7844.0938.0534.58
Price / Book0.573.667.334.28
Net Income$10.57M$94.03M$3.18B$247.04M
7 Day Performance-1.95%-4.75%-4.42%-4.36%
1 Month Performance-6.18%0.34%-6.07%-5.59%
1 Year Performance-35.24%1.39%11.42%3.39%

FONAR Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FONR
FONAR
1.934 of 5 stars
$14.57
-2.5%
N/A-35.2%$90.38M$101.57M12.67480
ZIMV
ZimVie
2.3758 of 5 stars
$13.32
+0.1%
$19.50
+46.4%
-20.4%$367.63M$457.43M-1.022,600Earnings Report
NYXH
Nyxoah
2.2898 of 5 stars
$10.36
+0.1%
$17.00
+64.1%
-32.9%$352.86M$4.70M-5.54110News Coverage
LUNG
Pulmonx
3.3389 of 5 stars
$8.92
-0.4%
$12.75
+42.9%
-10.9%$352.25M$83.79M-6.19250News Coverage
Gap Down
TCMD
Tactile Systems Technology
3.2259 of 5 stars
$14.90
-1.0%
$18.00
+20.8%
-8.2%$351.42M$292.98M21.29980Short Interest ↑
NNOX
Nano-X Imaging
1.771 of 5 stars
$6.02
-4.4%
$17.50
+190.7%
-48.7%$347.84M$9.90M-7.08190
CVRX
CVRx
2.366 of 5 stars
$13.16
-5.0%
$17.83
+35.5%
-40.6%$342.69M$51.29M-4.89160
SMTI
Sanara MedTech
2.6639 of 5 stars
$35.39
+5.0%
$47.00
+32.8%
-15.8%$309.31M$64.99M-35.7560News Coverage
AVR
Anteris Technologies Global
N/A$7.27
-11.9%
$16.50
+127.0%
N/A$261.28M$2.71M0.00138
RCEL
AVITA Medical
1.5199 of 5 stars
$9.41
-3.5%
$17.25
+83.3%
-51.7%$255.63M$64.25M-3.94130
ZYXI
Zynex
3.4414 of 5 stars
$7.36
+2.4%
$14.00
+90.2%
-41.4%$234.42M$184.32M49.071,100

Related Companies and Tools


This page (NASDAQ:FONR) was last updated on 3/4/2025 by MarketBeat.com Staff
From Our Partners